The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in income, its patent expiration created a wave of knock-off https://bookmarkssocial.com/story21335564/sildenafil-and-pharma-a-risky-opportunity